Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III

This study has been completed.
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Amir Lerman, Mayo Clinic Identifier:
First received: February 9, 2010
Last updated: January 7, 2016
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)